DOCSLIB.ORG

Selective Inactivation of USP18 Isopeptidase Activity in Vivo Enhances ISG15 Conjugation and Viral Resistance

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Selective Inactivation of USP18 Isopeptidase Activity in Vivo Enhances ISG15 Conjugation and Viral Resistance Selective inactivation of USP18 isopeptidase activity in vivo enhances ISG15 conjugation and viral resistance Lars Ketschera,b,1, Ronny Hannßc,d,1, David J. Moralese, Anja Bastersa,b, Susana Guerraf, Tobias Goldmanna, Annika Hausmanna, Marco Prinza,g, Ronald Naumannh, Andrew Pekoszi, Olaf Utermöhlenj,k, Deborah J. Lenschowe, and Klaus-Peter Knobelocha,2 aInstitute of Neuropathology, University of Freiburg, 79106 Freiburg, Germany; bFaculty of Biology, University of Freiburg, 79104 Freiburg, Germany; cDepartment of General, Visceral, Vascular and Thoracic Surgery, Division of Molecular Biology, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany; dFachbereich Biologie, Chemie, Pharmazie, Free University Berlin, 14195 Berlin, Germany; eDepartment of Medicine and Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110; fDepartment of Preventive Medicine, Public Health and Microbiology, Universidad Autónoma Madrid, 28029 Madrid, Spain; gCentre of Biological Signalling Studies (BIOSS), University of Freiburg, 79106 Freiburg, Germany; hMax Planck Institute of Molecular Cell Biology and Genetics, Transgenic Core Facility, 01307 Dresden, Germany; iW. Harry Feinstone Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205; jInstitute for Medical Microbiology, Immunology and Hygiene, Medical Center, University of Cologne, 50935 Cologne, Germany; and kCenter for Molecular Medicine Cologne, University of Cologne, 50931 Cologne, Germany Edited by Peter Palese, Icahn School of Medicine at Mount Sinai, New York, NY, and approved December 23, 2014 (received for review July 9, 2014) Protein modification by the ubiquitin-like protein ISG15 is an is also conjugated to cellular proteins. For example, ISGylation interferon (IFN) effector system, which plays a major role in antiviral increases the stability of the IFN regulatory factor 3 (IRF3), defense. ISG15 modification is counteracted by the isopeptidase resulting in enhanced activation of IRF3 target genes (11, 12). USP18, a major negative regulator of IFN signaling, which was also Consistent with the antiviral function, mice lacking ISG15 are shown to exert its regulatory function in an isopeptidase-indepen- more susceptible to influenza A and B, Sindbis, and herpes virus dent manner. To dissect enzymatic and nonenzymatic functions of infections (13). However, antiviral responses against vesicular USP18 in vivo, we generated knock-in mice (USP18C61A/C61A) express- stomatitis virus (VSV) and lymphocytic choriomeningitis virus C61A/C61A ing enzymatically inactive USP18. USP18 mice displayed in- (LCMV) are not altered (14). For both influenza B and Sindbis creased levels of ISG15 conjugates, validating that USP18 is a major virus infection, the antiviral function of ISG15 is dependent on its −/− C61A/C61A ISG15 isopeptidase in vivo. Unlike USP18 mice, USP18 ability to form conjugates because mice lacking the ISG15 E1 animals did not exhibit morphological abnormalities, fatal IFN hy- enzyme, UbE1L, are also susceptible to these infections (15, 16). persensitivity, or increased lethality, clearly showing that major Several viruses including influenza B virus, vaccinia virus (VACV), USP18 functions are unrelated to its protease activity. Strikingly, C61A/C61A and Crimean Congo hemorrhagic fever virus (CCHFV) have elevated ISGylation in USP18 mice was accompanied evolved strategies to target ISG15 conjugation, further suggesting by increased viral resistance against vaccinia virus and influenza B an important antiviral role of ISGylation (3, 17–19). virus infections. Enhanced resistance upon influenza B infection in C61A/C61A C61A/C61A Conjugation of ISG15 to its substrates is counteracted by the USP18 mice was completely reversed in USP18 mice, activity of ubiquitin-specific protease 18 (USP18/UBP43) (20). which additionally lack ISG15, providing evidence that the observed In vitro studies also provided evidence for other USPs to be reduction in viral titers is ISG15 dependent. These results suggest cross-reactive for ISG15, but the relevance of these isopeptidases that increasing ISGylation by specific inhibition of USP18 protease for deISGylation in vivo is unclear (21). Beyond enhanced activity could constitute a promising antiviral strategy with only a minimal risk of severe adverse effects. Significance ISG15 | UBP43 | interferon | ubiquitin isopeptidase | influenza Viral infections still constitute a major health issue. Upon viral MICROBIOLOGY infection, interferon (IFN) elicits an antiviral response by acti- rotein modification by the ubiquitin-like (UBL) modifier in- vating multiple effector systems. The ubiquitin-like protein Pterferon (IFN)-stimulated gene 15 (ISG15) is strongly induced ISG15 is strongly induced by IFN and mediates its antiviral ef- by type I IFNs and represents one of the major antiviral IFN ef- fect by being covalently conjugated to cellular and viral pro- fector systems (1). ISG15 has weak sequence identity to ubiquitin teins. The protease USP18, which is also an important negative and is structurally characterized by two ubiquitin-like domains regulator of the IFN response, counteracts ISG15 conjugation. connected by a short linker region (2). In analogy to ubiquitin, Within this study, we have generated knock-in mice expressing ISG15 is covalently conjugated to protein targets via the consecutive USP18, which selectively lacks protease activity. ISG15 modifi- action of an E1-activating enzyme (Ube1L) (3), an E2-conjugating cation was enhanced in these animals, but the IFN response enzyme (UbcH8) (4), and a few E3 ligases. All enzymes involved in was unaltered. This clearly shows that USP18 has enzymatic the conjugation process are themselves strongly inducible by type I and nonenzymatic properties in vivo. Elevated ISGylation in- IFNs. The major E3 ligases for human and murine ISG15 modifi- creased resistance to influenza B infections, qualifying USP18 cation (ISGylation) are hHERC5 (5, 6) and mHERC6 (7, 8), re- protease inhibition as a potential antiviral strategy. spectively. hHERC5 is associated with polyribosomes and newly synthesized proteins are modified by ISG15 in a cotranslational Author contributions: S.G., A.P., O.U., D.J.L., and K.-P.K. designed research; L.K., R.H., D.J.M., A.B., S.G., T.G., A.H., R.N., O.U., D.J.L., and K.-P.K. performed research; A.P. con- manner (9). Thus, it was suggested that ISG15 modification of virus- tributed new reagents/analytic tools; L.K., R.H., D.J.M., A.B., S.G., T.G., M.P., O.U., D.J.L., derived proteins, which are the most prevalent translational prod- and K.-P.K. analyzed data; and L.K., S.G., O.U., D.J.L., and K.-P.K. wrote the paper. ucts in a virus-infected cell, mediates the antiviral activity of the The authors declare no conflict of interest. ISGylation system. In line with this suggestion, ISG15 modification This article is a PNAS Direct Submission. of the human papilloma virus protein HPV16 L1 interfered with 1L.K. and R.H. contributed equally to this work. virus assembly and decreased the infectivity of HPV in a dominant 2To whom correspondence should be addressed. Email: klaus-peter.knobeloch@uniklinik- manner (9). Moreover, ISGylation of the influenza virus protein freiburg.de. α NS1A prevents interaction with importin- and thereby interferes This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. with the capability of NS1A to counteract host defense (10). ISG15 1073/pnas.1412881112/-/DCSupplemental. www.pnas.org/cgi/doi/10.1073/pnas.1412881112 PNAS | February 3, 2015 | vol. 112 | no. 5 | 1577–1582 Downloaded by guest on September 25, 2021 − − ISGylation, USP18 knockout (USP18 / ) mice develop severe brain a protease-independent manner (28). Thus, the enhanced malformations and have a shortened lifespan (22). In addition, ISGylation seen in the USP18-deficient mice could have been due these animals fail to properly terminate IFN-signaling, exhibit to either the enhanced IFN signaling or impaired deISGylation. In enhanced IFN target gene expression, and show lethal hyper- addition, previous in vitro studies have provided evidence for other sensitivity to poly(I:C) injections (23). Furthermore, IFN de- USPs that exhibit cross-reactivity to ISG15 (21, 29). Therefore, we sensitization, which assures long-term refractoriness of the IFN − − evaluated whether the loss of USP18 isopeptidase activity is suffi- signaling pathway, is abrogated in USP18 / mice (24), under- cient to augment ISG15 modification in vivo. USP18C61A/C61A or lining the role of USP18 as a critical negative regulator of the − − WT mice were stimulated with poly(I:C), and ISG15-conjugated IFN pathway. USP18 / mice also exhibit increased resistance to proteins were monitored in lysates from liver, lung, lymph nodes, intracranial (i.c.) infections with VSV and LCMV (25). The spleen, and thymus (Fig. 1A and Fig. S3A). In addition, ISG15 −/− phenotypic alterations seen in USP18 mice were first exclu- modification was analyzed in BMMs treated with IFN-α,IFN-β, sively ascribed to enhanced ISG15 modification. However, sub- poly(I:C), or LPS (Fig. 1B and Fig. S3B). Inactivation of the USP18 sequent analysis of mice doubly deficient for either USP18 and isopeptidase activity significantly increased levels of ISGylated ISG15 (26) or USP18 and Ube1L (27) surprisingly revealed that substrates upon IFN-β, poly(I:C), or LPS stimulation and in all the lack of ISGylation cannot rescue the brain
Load more

Recommended publications
  • Accepted Manuscript
    Accepted Manuscript Real-time kinetic method to monitor isopeptidase activity of transglutaminase 2 on protein substrate Kiruphagaran Thangaraju, Beáta Biri, Gitta Schlosser, Bence Kiss, László Nyitray, László Fésüs, Róbert Király PII: S0003-2697(16)30046-X DOI: 10.1016/j.ab.2016.04.012 Reference: YABIO 12363 To appear in: Analytical Biochemistry Received Date: 5 January 2016 Revised Date: 19 April 2016 Accepted Date: 19 April 2016 Please cite this article as: K. Thangaraju, B. Biri, G. Schlosser, B. Kiss, L. Nyitray, L. Fésüs, R. Király, Real-time kinetic method to monitor isopeptidase activity of transglutaminase 2 on protein substrate, Analytical Biochemistry (2016), doi: 10.1016/j.ab.2016.04.012. This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. ACCEPTED MANUSCRIPT Real-time kinetic method to monitor isopeptidase activity of transglutaminase 2 on protein substrate Real-time kinetic method to monitor isopeptidase activity of transglutaminase 2 on protein substrate Kiruphagaran Thangaraju a, Beáta Biri b, Gitta Schlosser c, Bence Kiss b, László Nyitray b, László Fésüs a,d,# and Róbert Király a,#* aDepartment of Biochemistry and
    [Show full text]
  • Clonado Y Expresión De Ubicuitina En Neurospora Crassa Taccioli, Guillermo 1989
    Tesis de Posgrado Clonado y expresión de ubicuitina en Neurospora crassa Taccioli, Guillermo 1989 Tesis presentada para obtener el grado de Doctor en Ciencias Químicas de la Universidad de Buenos Aires Este documento forma parte de la colección de tesis doctorales y de maestría de la Biblioteca Central Dr. Luis Federico Leloir, disponible en digital.bl.fcen.uba.ar. Su utilización debe ser acompañada por la cita bibliográfica con reconocimiento de la fuente. This document is part of the doctoral theses collection of the Central Library Dr. Luis Federico Leloir, available in digital.bl.fcen.uba.ar. It should be used accompanied by the corresponding citation acknowledging the source. Cita tipo APA: Taccioli, Guillermo. (1989). Clonado y expresión de ubicuitina en Neurospora crassa. Facultad de Ciencias Exactas y Naturales. Universidad de Buenos Aires. http://digital.bl.fcen.uba.ar/Download/Tesis/Tesis_2233_Taccioli.pdf Cita tipo Chicago: Taccioli, Guillermo. "Clonado y expresión de ubicuitina en Neurospora crassa". Tesis de Doctor. Facultad de Ciencias Exactas y Naturales. Universidad de Buenos Aires. 1989. http://digital.bl.fcen.uba.ar/Download/Tesis/Tesis_2233_Taccioli.pdf Dirección: Biblioteca Central Dr. Luis F. Leloir, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires. Contacto: [email protected] Intendente Güiraldes 2160 - C1428EGA - Tel. (++54 +11) 4789-9293 UNIVERSIDAD DE BUENOS AIRES Facultad de Ciencias Exactas y Naturales CLONADO Y EXPRESION DE UBICUITINA EN NEUROSPORA CRASSA Guillermo Taccioli Tesis para optar al título de Doctor en Ciencias Químicas Director: Dr. Norberto Daniel Judewicz 1989 e? o? 33 Instituto de Investigaciones en "OZ Ingeniería Genética-y Biología Molecular (INGEBI) CONICET AGRADECIMIENTOS Al Dr.
    [Show full text]
  • Emerging Roles of Deubiquitinating Enzymes in Human Cancer1
    Acta Pharmacol Sin 2007 Sep; 28 (9): 1325–1330 Invited review Emerging roles of deubiquitinating enzymes in human cancer1 Jin-ming YANG2 Department of Pharmacology, The Cancer Institute of New Jersey, University of Medicine and Dentistry of New Jersey/Robert Wood Johnson Medical School, New Brunswick, New Jersey 08903, USA Key words Abstract ubiquitin; cancer; deubiquitinating enzymes Protein modifications by the covalent linkage of ubiquitin have significant in- volvement in many cellular processes, including stress response, oncogenesis, 1 Project supported by grants from the US Health Service NIH/NCI (No CA109371) and viral infection, transcription, protein turnover, organelle biogenesis, DNA repair, (No CA66077). cellular differentiation, and cell cycle control. Protein ubiquitination and subse- 2 Correspondence to Dr Jin-ming YANG. quent degradation by the proteasome require the participation of both Phn 1-732-235-8075. Fax 1-732-235-8094. ubiquitinating enzymes and deubiquitinating enzymes. Although deubiquitinating E-mail [email protected] enzymes constitute a large family in the ubiquitin system, the study of this class of proteins is still in its infant stage. Recent studies have revealed a variety of Received 2007-04-24 Accepted 2007-07-12 molecular and biological functions of deubiquitinating enzymes and their associa- tion with human diseases. In this review we will discuss the possible roles that doi: 10.1111/j.1745-7254.2007.00687.x deubiquitinating enzymes may play in cancers. Introduction the ubiquitin/aggresome pathway. An important function of this mechanism is the degradation of abnormal proteins gen- The post-translational modification of proteins by the erated under normal and stress conditions.
    [Show full text]
  • Characterization of SENP7, a SUMO-2/-3 Specific Isopeptidase Lin Nan Shen, Marie-Claude Geoffroy, Ellis G Jaffray, Ronald T.Hay
    Characterization of SENP7, a SUMO-2/-3 specific isopeptidase Lin Nan Shen, Marie-Claude Geoffroy, Ellis G Jaffray, Ronald T.Hay To cite this version: Lin Nan Shen, Marie-Claude Geoffroy, Ellis G Jaffray, Ronald T. Hay. Characterization ofSENP7, a SUMO-2/-3 specific isopeptidase. Biochemical Journal, Portland Press, 2009, 421 (2), pp.223-230. 10.1042/BJ20090246. hal-00479165 HAL Id: hal-00479165 https://hal.archives-ouvertes.fr/hal-00479165 Submitted on 30 Apr 2010 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Biochemical Journal Immediate Publication. Published on 24 Apr 2009 as manuscript BJ20090246 Characterization of SENP7, a SUMO-2/-3 specific isopeptidase Lin Nan Shen, Marie-Claude Geoffroy, Ellis G. Jaffray, Ronald T. Hay* Wellcome Trust Centre for Gene Regulation and Expression, school of Life Sciences, University of Dundee, Dow Street, Dundee DD1 5EH, UK. * communicating author Modification of proteins by SUMO (Small Ubiqutin-like Modifer) plays important roles in regulating the activity, stability and cellular localization of target proteins. Like ubiquitination, SUMO modification is a dynamic process that can be reversed by SUMO-specific proteases (SENPs). So far, six SENPs have been discovered in humans although knowledge of their regulation, specificity and biological functions is limited.
    [Show full text]
  • Assay Systems for Profiling Deubiquitinating Activity
    International Journal of Molecular Sciences Review Assay Systems for Profiling Deubiquitinating Activity 1, 2, 1 3, Jinhong Cho y , Jinyoung Park y, Eunice EunKyeong Kim and Eun Joo Song * 1 Biomedical Research Institute, Korea Institute of Science and Technology, Seoul 02792, Korea; [email protected] (J.C.); [email protected] (E.E.K.) 2 Molecular Recognition Research Center, Korea Institute of Science and Technology, Seoul 02792, Korea; [email protected] 3 Graduate School of Pharmaceutical Sciences and College of Pharmacy, Ewha Womans University, Seoul 03760, Korea * Correspondence: [email protected]; Tel.: +82-(2)-3277-3373 These authors contributed equally to this work. y Received: 1 July 2020; Accepted: 4 August 2020; Published: 6 August 2020 Abstract: Deubiquitinating enzymes regulate various cellular processes, particularly protein degradation, localization, and protein–protein interactions. The dysregulation of deubiquitinating enzyme (DUB) activity has been linked to several diseases; however, the function of many DUBs has not been identified. Therefore, the development of methods to assess DUB activity is important to identify novel DUBs, characterize DUB selectivity, and profile dynamic DUB substrates. Here, we review various methods of evaluating DUB activity using cell lysates or purified DUBs, as well as the types of probes used in these methods. In addition, we introduce some techniques that can deliver DUB probes into the cells and cell-permeable activity-based probes to directly visualize and quantify DUB activity in live cells. This review could contribute to the development of DUB inhibitors by providing important information on the characteristics and applications of various probes used to evaluate and detect DUB activity in vitro and in vivo.
    [Show full text]
  • Isopeptidase Kinetics Determination by a Real Time and Sensitive Qfret Approach
    biomolecules Article Isopeptidase Kinetics Determination by a Real Time and Sensitive qFRET Approach Yan Liu 1,†, Yali Shen 2,†, Yang Song 1, Lei Xu 3 , J. Jefferson P. Perry 4,* and Jiayu Liao 1,2,4,* 1 Department of Bioengineering, Bourns College of Engineering, University of California at Riverside, 900 University Avenue, Riverside, CA 92521, USA; [email protected] (Y.L.); [email protected] (Y.S.) 2 Department of Abdominal Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China; [email protected] 3 Department of Geography & the Environment, California State University, Fullerton, 800 N State College Blvd, Fullerton, CA 92831, USA; [email protected] 4 Department of Biochemistry, University of California at Riverside, 900 University Avenue, Riverside, CA 92521, USA * Correspondence: [email protected] (J.J.P.P.); [email protected] (J.L.) † These authors have contributed equally to this work. Abstract: Isopeptidase activity of proteases plays critical roles in physiological and pathological processes in living organisms, such as protein stability in cancers and protein activity in infectious diseases. However, the kinetics of protease isopeptidase activity has not been explored before due to a lack of methodology. Here, we report the development of novel qFRET-based protease assay for characterizing the isopeptidase kinetics of SENP1. The reversible process of SUMOylation in vivo requires an enzymatic cascade that includes E1, E2, and E3 enzymes and Sentrin/SUMO-specific proteases (SENPs), which can act either as endopeptidases that process the pre-SUMO before its conjugation, or as isopeptidases to deconjugate SUMO from its target substrate. We first produced the isopeptidase substrate of CyPet-SUMO1/YPet-RanGAP1c by SUMOylation reaction in the presence Citation: Liu, Y.; Shen, Y.; Song, Y.; of SUMO E1 and E2 enzymes.
    [Show full text]
  • Recognition of the Polyubiquitin Proteolytic Signal
    The EMBO Journal Vol.19 No.1 pp.94–102, 2000 Recognition of the polyubiquitin proteolytic signal Julia S.Thrower, Laura Hoffman1, with the ATP-dependent activation of Ub by an activating Martin Rechsteiner1 and Cecile M.Pickart2 enzyme (E1). The ligation of ubiquitin to the substrate is then carried out by a specific complex composed of a Department of Biochemistry and Molecular Biology, School of Public Ub–protein ligase (E3) and a Ub conjugating enzyme Health, Johns Hopkins University, 615 North Wolfe Street, Baltimore, (E2), with the E3 being the primary substrate specificity MD 21205 and 1Department of Biochemistry, School of Medicine, University of Utah, Salt Lake City, UT 84132, USA factor (Hershko and Ciechanover, 1998). During this recognition phase, many Ubs are ligated to the substrate, 2Corresponding author e-mail: [email protected] usually in the form of a polymeric chain (Chau et al., 1989). PolyUb chains linked through K48–G76 isopeptide Polyubiquitin chains linked through Lys48 are the bonds are the principal signal for proteasomal proteolysis principal signal for targeting substrates to the 26S (Chau et al., 1989; Finley et al., 1994). proteasome. Through studies of structurally defined, The 26S proteasome is a 2.1 MDa complex whose polyubiquitylated model substrates, we show that tetra- ~65 subunits are divided among three subcomplexes ubiquitin is the minimum signal for efficient protea- (Baumeister et al., 1998; Rechsteiner, 1998). One subcom- somal targeting. The mechanism of targeting involves plex, the 20S proteasome, is a cylindrical stack of four a simple increase in substrate affinity that is brought seven-membered rings.
    [Show full text]
  • Regulation of Deubiquitinating Enzymes by Post-Translational Modifications
    International Journal of Molecular Sciences Review Regulation of Deubiquitinating Enzymes by Post-Translational Modifications Tanuza Das 1, Sang Chul Shin 1, Eun Joo Song 2 and Eunice EunKyeong Kim 1,* 1 Biomedical Research Institute, Korea Institute of Science and Technology, Seoul 02792, Korea; [email protected] (T.D.); [email protected] (S.C.S.) 2 Graduate School of Pharmaceutical Sciences and College of Pharmacy, Ewha Womans University, Seoul 03760, Korea; [email protected] * Correspondence: [email protected]; Tel.: +82-2-958-5937 Received: 12 May 2020; Accepted: 1 June 2020; Published: 4 June 2020 Abstract: Ubiquitination and deubiquitination play a critical role in all aspects of cellular processes, and the enzymes involved are tightly regulated by multiple factors including posttranslational modifications like most other proteins. Dysfunction or misregulation of these enzymes could have dramatic physiological consequences, sometimes leading to diseases. Therefore, it is important to have a clear understanding of these regulatory processes. Here, we have reviewed the posttranslational modifications of deubiquitinating enzymes and their consequences on the catalytic activity, stability, abundance, localization, and interaction with the partner proteins. Keywords: post-translational modification (PTM); deubiquitinase (DUB); deubiquitinating enzyme; activity; localization; interaction; disease 1. Introduction Ubiquitination, the covalent attachment of 76 amino acid polypeptide ubiquitin (Ub) to a substrate protein, is a reversible post-translational modification (PTM) process involved in the regulation of most cellular processes. Ubiquitination affects the target proteins in many ways: marks them for degradation via the proteasome, alters their specific location in the cell, affects their activity or stability, and promotes or prevents interactions with their partners.
    [Show full text]
  • Lasso Peptides with an Aspartimide Post-Translational Modification Li Cao†, Moshe Beiser‡, Joseph D
    bioRxiv preprint doi: https://doi.org/10.1101/2021.05.19.444711; this version posted May 19, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Cellulonodin-2 and Lihuanodin: Lasso Peptides with an Aspartimide Post-translational Modification Li Cao†, Moshe Beiser‡, Joseph D. Koos§, Margarita Orlova†, Hader E. Elashal†, Hendrik V. Schröder†, A. James Link†,‡,§,* †Department of Chemical and Biological Engineering, Princeton University, Princeton, NJ 08544, United States ‡Department of Chemistry, Princeton University, Princeton, NJ 08544, United States §Department of Molecular Biology, Princeton University, Princeton, NJ 08544, United States *Corresponding author: [email protected] Abstract: Lasso peptides are a family of ribosomally synthesized and post-translationally modified peptides (RiPPs) defined by their threaded structure. Besides the class-defining isopeptide bond, other post-translational modifications (PTMs) that further tailor lasso peptides have been previously reported. Using genome mining tools, we identified a subset of lasso peptide biosynthetic gene clusters (BGCs) that are colocalized with protein L-isoaspartyl methyltransferase (PIMT) homologs. PIMTs have an important role in protein repair, restoring isoaspartate residues formed from asparagine deamidation to aspartate. Here we report a new function for PIMT enzymes in the post-translational modification of lasso peptides. The PIMTs associated with lasso peptide BGCs first methylate an L-aspartate sidechain found within the ring of the lasso peptide. The methyl ester is then converted into a stable aspartimide moiety, endowing the lasso peptide ring with rigidity relative to its unmodified counterpart. We describe the heterologous expression and structural characterization of two examples of aspartimide- modified lasso peptides from thermophilic Gram-positive bacteria.
    [Show full text]
  • Surface Hydrophobic Residues of Multiubiquitin Chains Essential for Proteolytic Targeting
    Proc. Natl. Acad. Sci. USA Vol. 93, pp. 861-866, January 1996 Biochemistry Surface hydrophobic residues of multiubiquitin chains essential for proteolytic targeting RICHARD BEAL*t, QUINN DEVERAUXt, GANG XIA*t, MARTIN RECHSTEINERt, AND CECILE PICKART*t§ *Department of Biochemistry, School of Medicine and Biomedical Sciences, State University of New York, Buffalo, NY 14214; and tDepartment of Biochemistry, University of Utah School of Medicine, Salt Lake City, UT 84132 Communicated by Sidney Velick, University of Utah, Salt Lake City, UT, November 8, 1995 (received for review July 21, 1995) ABSTRACT Ubiquitin conjugation is a signal for degra- interaction between multiubiquitin chains and S5a remains dation of eukaryotic proteins by the 26S protease. Conjuga- completely uncharacterized. We used the recently determined tion of a homopolymeric multiubiquitin chain to a substrate structure of tetraubiquitin (Ub4) (19) as a starting point to lysine residue results in 10-fold faster degradation than does address this question by site-specific mutagenesis. Here we conjugation of monoubiquitin, but the molecular basis of report evidence concerning the molecular interactions respon- enhanced targeting by chains is unknown. We show that sible for enhanced proteolytic targeting by multiubiquitin ubiquitin residues L8, I44, and V70 are critical for targeting. chains. Mutation of pairs of these residues to alanine had little effect on attachment ofubiquitin to substrates but severely inhibited degradation of the resulting conjugates. The same mutations MATERIALS AND METHODS blocked the binding of chains to a specific subunit (S5a) ofthe Ubiquitin Mutagenesis, Expression, and Purification. Plas- regulatory complex of the 26S protease. The side chains mids encoding mutant ubiquitins were generated by whole- implicated in this binding-L8, 144, and V70-form repeating plasmid (circular) PCR using pPLhUb as template (20).
    [Show full text]
  • Isopeptidase Activity of Human Transglutaminase 2: Disconnection from Transamidation and Characterization by Kinetic Parameters
    Isopeptidase activity of human transglutaminase 2: disconnection from transamidation and characterization by kinetic parameters Róbert Király1, Kiruphagaran Thangaraju1, Zsófia Nagy1, Russell Collighan3, Zoltán Nemes1, Martin Griffin3# and László Fésüs1,2#* 1Department of Biochemistry and Molecular Biology, 2MTA-DE Stem cell, Apoptosis and Genomics Research Group of Hungarian Academy of Sciences, Faculty of Medicine, University of Debrecen, Egyetem tér 1., Debrecen, Hungary H-4012; Phone: +36 52 416-432; Fax: +36 52 314-989; E-mail: [email protected] 3School of Life and Health Sciences, Aston University, Birmingham, United Kingdom #These authors contributed equally to this study *Corresponding author The final publication is available at Springer via http://dx.doi.org/[10.1007/s00726-015-2063-5] Abstract Transglutaminase 2 (TG2) is a multifunctional protein with diverse catalytic activities and biological roles. Its best studied function is the Ca2+-dependent transamidase activity leading to formation of γ-glutamyl-ε-lysine isopeptide crosslinks between proteins or γ-glutamyl-amine derivatives. TG2 has a poorly studied isopeptidase activity cleaving these bonds. We have developed and characterised TG2 mutants which are significantly deficient in transamidase activity while have normal or increased isopeptidase activity (W332F) and vice versa (W278F). The W332F mutation led to significant changes of both the Km and the Vmax kinetic parameters of the isopeptidase reaction of TG2 while its calcium and GTP sensitivity was similar to the wild type enzyme. The W278F mutation resulted in six times elevated amine incorporating transamidase activity demonstrating the regulatory significance of W278 and W332 in TG2 and that mutations can change opposed activities located at the same active site.
    [Show full text]
  • The Emerging Role of Deubiquitinating Enzymes in Genomic Integrity, Diseases, and Therapeutics Mingjing He1,2, Zhuan Zhou1, Anil A
    He et al. Cell Biosci (2016) 6:62 DOI 10.1186/s13578-016-0127-1 Cell & Bioscience REVIEW Open Access The emerging role of deubiquitinating enzymes in genomic integrity, diseases, and therapeutics Mingjing He1,2, Zhuan Zhou1, Anil A. Shah1, Haojing Zou1, Jin Tao1, Qianming Chen2 and Yong Wan1* Abstract The addition of mono-ubiquitin or poly-ubiquitin chain to signaling proteins in response to DNA damage signal is thought to be a critical event that facilitates the recognition of DNA damage lesion site, the activation of checkpoint function, termination and checkpoint response and the recruitment of DNA repair proteins. Despite the ubiquitin modifiers, removal of ubiquitin from the functional proteins by the deubiquitinating enzymes (DUBs) plays an impor- tant role in orchestrating DNA damage response as well as DNA repair processes. Deregulated ubiquitination and deubiquitination could lead to genome instability that in turn causes tumorigenesis. Recent TCGA study has further revealed the connection between mutations in alteration of DUBs and various types of tumors. In addition, emerg- ing drug design based on DUBs provides a new avenue for anti-cancer therapy. In this review, we will summarize the role of deubiquitination and specificity of DUBs, and highlight the recent discoveries of DUBs in the modulation of ubiquitin-mediated DNA damage response and DNA damage repair. We will furthermore discuss the DUBs involved in the tumorigenesis as well as interception of deubiquitination as a novel strategy for anti-cancer therapy. Keywords: Deubiquitinases, DNA damage response, DNA damage repair, Tumorigenesis, Anti-cancer treatment Background Ubiquitination, a posttranslational modification cova- Genomic integrity is constantly challenged by DNA lently attaching ubiquitin to targeted proteins, deter- lesions produced as by-products of normal cellular mines or alters protein’s biological activity, stability or metabolism, DNA replication or induced by radiation subcellular localization.
    [Show full text]